To further investigate whether the role of CDT2 and DDB2 in cancer patients were related to DDB2 mediated CDT2 degradation, we analyzed expression of CDT2 and DDB2 in ovarian teratoma and breast cancer tissues using immunohistochemistry. The gene discussed is DTL; the disease is breast carcinoma.